PortfoliosLab logo

Burning Rock Biotech Limited (BNR)

Equity · Currency in USD · Last updated Mar 21, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Burning Rock Biotech Limited in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,177 for a total return of roughly -88.23%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%NovemberDecember2023FebruaryMarch
17.82%
7.42%
BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BNR

Burning Rock Biotech Limited

Return

Burning Rock Biotech Limited had a return of 28.89% year-to-date (YTD) and -68.58% in the last 12 months. Over the past 10 years, Burning Rock Biotech Limited had an annualized return of -53.91%, while the S&P 500 had an annualized return of 9.94%, indicating that Burning Rock Biotech Limited did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-6.45%-3.13%
Year-To-Date28.89%2.92%
6 months-10.49%2.02%
1 year-68.58%-11.46%
5 years (annualized)-53.91%9.94%
10 years (annualized)-53.91%9.94%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202329.33%12.03%
2022-39.03%-13.81%21.84%-10.36%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Burning Rock Biotech Limited Sharpe ratio is -0.70. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20NovemberDecember2023FebruaryMarch
-0.70
-0.45
BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)

Dividend History


Burning Rock Biotech Limited doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-92.67%
-17.62%
BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Burning Rock Biotech Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Burning Rock Biotech Limited is 95.63%, recorded on Oct 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.63%Feb 23, 2021422Oct 24, 2022
-39.33%Jun 24, 202054Sep 9, 202089Jan 15, 2021143
-25.28%Jan 22, 20214Jan 27, 202117Feb 22, 202121
-5.77%Jun 15, 20201Jun 15, 20203Jun 18, 20204
-1.38%Jan 20, 20211Jan 20, 20211Jan 21, 20212

Volatility Chart

Current Burning Rock Biotech Limited volatility is 55.85%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%NovemberDecember2023FebruaryMarch
55.85%
20.82%
BNR (Burning Rock Biotech Limited)
Benchmark (^GSPC)